| Date Filed | Type | Description |
| 04/28/2023 |
3/A
| Farrow Jeffrey S (See Remarks) has filed a Form 3/A on Tarsus Pharmaceuticals, Inc. |
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2022 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,885 shares
@ $68.15, valued at
$128.5k
Sold 31,441 shares
@ $68, valued at
$2.1M
Exercised 2,763 restricted stock units
@ $0
Exercised 2,208 restricted stock units
@ $0 |
|
| 08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 4,506 shares
@ $29.33, valued at
$132.2k
Exercised 2,875 restricted stock units
@ $0
Exercised 3,125 restricted stock units
@ $0
Exercised 3,020 restricted stock units
@ $0 |
|
| 09/24/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2020 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 5,946 shares
@ $67.48, valued at
$401.2k
Exercised 3,062 restricted stock units
@ $0
Exercised 2,875 restricted stock units
@ $0
Exercised 3,125 restricted stock units
@ $0
Exercised 3,020 restricted stock units
@ $0 |
|
| 07/15/2020 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Sold 15,208 shares
@ $75, valued at
$1.1M
|
|
| 06/11/2020 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Sold 15,208 shares
@ $67, valued at
$1M
|
|
| 06/03/2020 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Granted 42,400 restricted stock units
@ $0 |
|
| 02/04/2020 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 4,398 shares
@ $65.26, valued at
$287k
Exercised 3,063 restricted stock units
@ $0
Exercised 2,875 restricted stock units
@ $0
Exercised 3,125 restricted stock units
@ $0
Granted 24,160 restricted stock units
@ $0
Granted 38,500 options to buy
@ $65.82, valued at
$2.5M
|
|
| 12/17/2019 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,479 shares
@ $76.88, valued at
$190.6k
Exercised 5,000 restricted stock units
@ $0 |
|
| 08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/10/2019 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 692 shares
@ $58.51, valued at
$40.5k
Exercised 2,000 restricted stock units
@ $0 |
|
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2018 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Exercised 3,048 options to buy
@ $16.4, valued at
$50k
|
|
| 08/03/2018 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,400 shares
@ $43.15, valued at
$103.6k
Exercised 3,062 restricted stock units
@ $0
Exercised 2,875 restricted stock units
@ $0 |
|
| 02/16/2018 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 692 shares
@ $62.3, valued at
$43.1k
Exercised 2,000 restricted stock units
@ $0 |
|
| 02/02/2018 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 692 shares
@ $57.9, valued at
$40.1k
Paid exercise price by delivering 1,060 shares
@ $59.6, valued at
$63.2k
Exercised 2,000 restricted stock units
@ $0
Exercised 3,063 restricted stock units
@ $0
Granted 35,000 options to buy
@ $59.6, valued at
$2.1M
Granted 23,000 restricted stock units
@ $0 |
|
| 01/26/2018 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 683 shares
@ $58.15, valued at
$39.7k
Exercised 2,000 restricted stock units
@ $0 |
|
| 01/18/2018 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 877 shares
@ $52.1, valued at
$45.7k
Exercised 2,000 restricted stock units
@ $0 |
|
| 08/14/2017 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Granted 15,000 restricted stock units
@ $0 |
|
| 08/03/2017 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,151 shares
@ $25.1, valued at
$28.9k
Exercised 3,062 restricted stock units
@ $0 |
|
| 01/19/2017 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc. |
| 04/04/2016 |
3
| Farrow Jeffrey S (CFO) has filed a Form 3 on Global Blood Therapeutics, Inc. |
| 12/21/2015 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on ZS Pharma, Inc.|
Txns:
| Disposed/sold 77,900 options to buy
@ $56.31, valued at
$4.4M
Disposed/sold 7,100 options to buy
@ $56.31, valued at
$399.8k
Disposed/sold 7,100 options to buy
@ $56.31, valued at
$399.8k
|
|
|